Posterior reversible encephalopathy syndrome (PRES): diagnosis and management

JD Triplett, MA Kutlubaev, AG Kermode, T Hardy - Practical Neurology, 2022 - pn.bmj.com
Posterior reversible encephalopathy syndrome (PRES) may present with diverse clinical
symptoms including visual disturbance, headache, seizures and impaired consciousness …

Immune-mediated conditions affecting the brain, eye and ear (BEE syndromes)

JD Triplett, KA Buzzard, M Lubomski… - Journal of Neurology …, 2019 - jnnp.bmj.com
The triad of central nervous system symptoms, visual disturbance and hearing impairment is
an oft-encountered clinical scenario. A number of immune-mediated diseases should be …

Immune checkpoint inhibitor-associated myopathy: a clinicoseropathologically distinct myopathy

S Shelly, JD Triplett, MV Pinto, M Milone… - Brain …, 2020 - academic.oup.com
Immune checkpoint inhibitors have revolutionized the landscape of cancer treatment.
Alongside their many advantages, they elicit immune-related adverse events, including …

Diagnosis, differential diagnosis and misdiagnosis of Susac syndrome

JD Triplett, J Qiu, B O'Brien, S Gopinath… - European journal of …, 2022 - Wiley Online Library
Background and purpose Susac syndrome (SuS) is an inflammatory condition of the brain,
eye and ear. Diagnosis can be challenging, and misdiagnosis is common. Methods This is a …

Cephalosporin-related neurotoxicity: metabolic encephalopathy or non-convulsive status epilepticus?

JD Triplett, ND Lawn, J Chan, JW Dunne - Journal of Clinical Neuroscience, 2019 - Elsevier
Abstract Metabolic encephalopathy and Non-Convulsive Status Epilepticus (NCSE) have
been reported with cephalosporin use, particularly cefepime. We aimed to analyze the …

Pregnancy outcomes amongst multiple sclerosis females with third trimester natalizumab use

JD Triplett, S Vijayan, S Rajanayagam, P Tuch… - Multiple sclerosis and …, 2020 - Elsevier
Background Natalizumab, a monoclonal antibody directed against alpha-4-integrin, is an
efficacious treatment used in Multiple Sclerosis (MS). Use in early pregnancy is safe but …

Immune‐mediated necrotizing myopathy: unusual presentations of a treatable disease

S Nicolau, M Milone, JA Tracy, JR Mills… - Muscle & …, 2021 - Wiley Online Library
Abstract Introduction/Aims Immune‐mediated necrotizing myopathy (IMNM) is an immune‐
mediated myopathy typically presenting with progressive subacute weakness and …

Diagnostic modelling and therapeutic monitoring of immune-mediated necrotizing myopathy: role of electrical myotonia

JD Triplett, S Shelly, G Livne, M Milone… - Brain …, 2020 - academic.oup.com
Delayed diagnosis of immune-mediated necrotizing myopathy leads to increased morbidity.
Patients with the chronic course without 3-hydroxy-3-methylglutaryl-coenzyme-A reductase …

Latency of multifocal visual evoked potential in multiple sclerosis: a visual pathway biomarker for clinical trials of remyelinating therapies

A Klistorner, JD Triplett, MH Barnett… - Journal of Clinical …, 2021 - journals.lww.com
Purpose: Acute focal demyelination is the characteristic feature of multiple sclerosis, with the
majority of damaged axons undergoing limited remyelination and forming chronic lesions …

Baclofen neurotoxicity: a metabolic encephalopathy susceptible to exacerbation by benzodiazepine therapy

JD Triplett, ND Lawn, JW Dunne - Journal of Clinical …, 2019 - journals.lww.com
Purpose: Baclofen has been reported to cause both a metabolic encephalopathy and
nonconvulsive status epilepticus. Baclofen is typically used in the management of muscle …